Glaukos Corporation (GKOS): Price and Financial Metrics


Glaukos Corporation (GKOS)

Today's Latest Price: $42.72 USD

2.15 (-4.79%)

Updated Jun 4 6:40pm

Add GKOS to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 132 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

GKOS Stock Summary

  • GKOS's price/sales ratio is 7.93; that's higher than the P/S ratio of 84.78% of US stocks.
  • With a year-over-year growth in debt of 498.96%, GLAUKOS Corp's debt growth rate surpasses 96.36% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, GLAUKOS Corp is reporting a growth rate of 817.83%; that's higher than 98.34% of US stocks.
  • If you're looking for stocks that are quantitatively similar to GLAUKOS Corp, a group of peers worth examining would be VRNS, VCEL, LPSN, ORGS, and REFR.
  • GKOS's SEC filings can be seen here. And to visit GLAUKOS Corp's official web site, go to www.glaukos.com.
GKOS Daily Price Range
GKOS 52-Week Price Range

GKOS Stock Price Chart More Charts


GKOS Price/Volume Stats

Current price $42.72 52-week high $84.65
Prev. close $44.87 52-week low $23.31
Day low $42.43 Volume 585,700
Day high $44.63 Avg. volume 821,421
50-day MA $35.90 Dividend yield N/A
200-day MA $53.16 Market Cap 1.89B

Glaukos Corporation (GKOS) Company Bio


Glaukos Corporation develops and commercializes products and procedures designed for the treatment of glaucoma. The company was founded in 1998 and is based in Laguna Hills, California.


GKOS Latest News Stream


Event/TimeNews Detail
Loading, please wait...

GKOS Latest Social Stream


Loading social stream, please wait...

View Full GKOS Social Stream

Latest GKOS News From Around the Web

Below are the latest news stories about GLAUKOS Corp that investors may wish to consider to help them evaluate GKOS as an investment opportunity.

Edited Transcript of GKOS earnings conference call or presentation 7-May-20 8:30pm GMT

Q1 2020 Glaukos Corp Earnings Call

Yahoo | June 4, 2020

Glaukos Announces Participation in the William Blair 40th Annual Growth Stock Conference

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced that its management is scheduled to virtually participate in the William Blair 40th Annual Growth Stock Conference on Wednesday, June 10, 2020, at 3:20 p.m. CDT.

Yahoo | June 2, 2020

Glaukos Technologies Featured in Numerous Presentations at the 2020 American Society of Cataract and Refractive Surgery Virtual Annual Meeting

Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its technologies will be featured in various "on demand" presentations at the American Society of Cataract and Refractive Surgery (ASCRS) Virtual Annual Meeting, which will be held online on May 16-17, 2020.

Yahoo | May 15, 2020

Glaukos (GKOS) Q1 2020 Earnings Call Transcript

Image source: The Motley Fool. Glaukos (NYSE: GKOS)Q1 2020 Earnings CallMay 07, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorWelcome to Glaukos Corporation's first-quarter 2020 financial results conference call.

Yahoo | May 9, 2020

Glaukos (GKOS) Q1 Earnings and Revenues Miss Estimates

Glaukos (GKOS) witnessed a contraction in gross margin but year-over-year revenue surge in Q1.

Zacks Investment Research | May 8, 2020

Read More 'GKOS' Stories Here

GKOS Price Returns

1-mo 4.94%
3-mo 8.15%
6-mo -28.73%
1-year -37.34%
3-year 9.48%
5-year N/A
YTD -21.57%
2019 -3.03%
2018 118.99%
2017 -25.22%
2016 38.92%
2015 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8729 seconds.